GW Pharma to launch first CBD-based epilepsy drug in Europe 'over the next year or two,' CEO says
September 24, 2019 at 20:19 PM EDT
"We have 28 countries now in Europe that have approved Epidyolex" to treat epilepsy seizures, GW Pharma CEO Justin Gover says.
